H1 Connect helps healthcare professionals find & participate in humanitarian aid work around the world by working closely with our leading NGO partners to identify opportunities. If you’re interested in joining our growing network of more than 6,000 HCPs and gain access to medical deployment opportunities, sign up here today: https://hubs.la/Q02MV2Ll0
H1
Software-Entwicklung
New York, NY 17,107 followers
H1 is the connecting force for global HCP, clinical, scientific and research information.
Über uns
At H1, our mission is nothing short of creating a healthier future worldwide by unlocking and democratizing global access to critical expertise, HCP information, claims data, ground-breaking research and discoveries, and connected insights for all – doctors, researchers, industry and, ultimately, patients – bringing everyone closer together to advance medicine and clinical outcomes. Insights derived from H1’s solutions help life sciences and other healthcare organizations accelerate the development, launch, and dissemination of life-saving treatments, drive meaningful engagements with key opinion leaders, and help ensure equitable access to healthcare services.
- Website
-
https://h1.co
External link for H1
- Industrie
- Software-Entwicklung
- Größe des Unternehmens
- 201-500 Mitarbeiter
- Hauptsitz
- New York, NY
- Typ
- In Privatbesitz
- Gegründet
- 2017
- Spezialitäten
- healthcare, provider data, healthcare professional information, diversity data, medical affairs, pharmaceutical, data science, medical science liaison, msl education, key opinion leaders, kol mapping, biotechnology, life sciences, healthcare data, HCPs, SaaS, healthcare content, clinical trials, clinical operations, and global drug development
Standorte
-
Primäre
373 Park Ave S
4th Floor
New York, NY 10016, US
Employees at H1
Aktualisierungen
-
#MSLS kicks off next week! If you're attending, we'd love to catch up with you in booth 9 and find out how we can support your needs for #KOLmapping, measuring impact, and whatever else you'd like to discuss. Don't miss our breakout session on Wednesday afternoon. Christine Medeiros and Robert Consalvo have a powerful presentation to share. See you in next week! https://lnkd.in/gdtHbKx #MSL #MSLS #MedicalAffairs #MSLSociety #12thAnnualMSLSConference
-
-
Empower your MSLs with comprehensive #HCPinsights. Kristin Cova, PharmD, and Christine Medeiros discuss strategies for optimizing #HCPengagement through digital tools. Discover how H1's detailed insights on HCP research interests, publications, and clinical activities enable MSLs to quickly tailor their communications to each HCP's latest focus for better connections. Watch now! https://hubs.ly/Q02M2jkY0 #medicalaffairs #msls #hcpdata #hcpinsights
-
Johnson & Johnson’s new FDA approval of its regimen to treat #lungcancer has launched it into a strong competitive position against the leading drug. In the phase 3 trial, J&J’s drug combination reduced the risk of disease progression or death by 30% compared with the leading drug as first-line treatments for EGFR-mutant non-small cell lung cancer. Patients who took the combo lived a median 23.7 months without progression, versus 16.6 months for the leading treatment. Learn more: https://hubs.la/Q02MlnJB0
-
In the face of ongoing medical challenges in Ukraine, H1 and Global Response Medicine (GRM) are stepping up to make a difference. By collaborating with H1, GRM efficiently recruited and deployed top-tier surgeons to support humanitarian efforts in the region. Our CEO Ariel Katz's conversation with Liza Laws at Outsourcing-Pharma provides valuable insights into this impactful partnership. Check out the interview to see how our H1 Connect platform links doctors with global missions to drive positive change: https://hubs.la/Q02MlmSk0 #HumanitarianEfforts #GlobalResponseMedicine #MedicalAid #H1Connect #UkraineAid
H1 Connect links doctors to global humanitarian missions
outsourcing-pharma.com
-
A top 10 pharma company recently engaged H1 to identify thought leaders in obstructive sleep apnea. Together, the medical team and H1 were able to discover relevant experts and prepare for an early launch. How did they accomplish this? Check out the full case study and learn how this pharma company was able to leverage H1 for success! https://hubs.la/Q02Mc2V10 #obstructivesleepapnea #osa #kols #hcpengagement #hcpdiscovery
-
Curious how a top leader in field medical strategy is helping her team make more impactful interactions with #HCPs? Kristin Cova, PharmD, Director of Medical Science Liaisons at Ferring Pharmaceuticals, shares how she leverages H1 to drive enhanced #HCPengagement. From pre-call planning to territory management, discover how Kristin uses digital tools to maximize efficiency and foster meaningful scientific dialogue with HCPs. See more here: https://hubs.la/Q02M1xhV0
-
At H1, we’re proud of the ways we work alongside top life sciences companies to create meaningful change in healthcare and to improve patient lives. See how our data insights have helped transform the way medical and clinical teams work – with a broader and deeper understanding of the healthcare landscape. Learn more: https://hubs.la/Q02LXYDt0
-
Unlock the key to effective HCP engagement. In an exclusive interview, Kristin Cova, PharmD from Ferring Pharmaceuticals discusses with Christine Medeiros how to amplify your #HCPengagement strategy and find the most influential #HCPs for impactful scientific exchange using H1. Watch now to learn how H1 is boosting #MSL impact in the field. https://hubs.ly/Q02LyPlc0 #hcps #scientificexchange #msls #ferring #ferringpharmaceuticals
-
Ascendis Pharma is celebrating a long-awaited FDA approval of their hormone replacement therapy to treat #hypoparathyroidism. After unanticipated delays have pushed the timeline back more than a year, the company is thrilled to finally be moving closer to launch. Hypoparathyroidism affects more 70,000+ patients in the U.S. and can lead to kidney complications and cognitive impairment. Ascendis’ therapy allowed 95% of patients to be freed from conventional therapy in a phase 3 trial. We’re happy to know patients will soon have this new treatment option available to them! https://hubs.la/Q02KZQyH0
Ascendis scores hard-fought FDA nod for hormone replacement therapy Yorvipath
fiercepharma.com